![Russell Hawkinson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russell Hawkinson
Geen lopende functies
Profiel
Russell Hawkinson worked as Vice President-Finance & Accounting at CTI BioPharma Corp.
from 2006 to 2007.
He then worked as Vice President-Finance at Corixa Corp.
from 1995 to 2005.
From 2007 to 2018, he served as Chief Financial Officer at Theraclone Sciences, Inc. He also worked as an Audit Senior Manager at Ernst & Young LLP (Missouri).
In addition, he worked as Chief Financial Officer at OncoResponse, Inc. from 2015 to 2018.
Most recently, he served as Senior Vice President-Finance at Silverback Therapeutics, Inc. from 2020 to 2022.
Mr. Hawkinson received his undergraduate degree from the University of Washington.
Eerdere bekende functies van Russell Hawkinson
| Bedrijven | Functie | Einde |
|---|---|---|
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Financieel Directeur/CFO | 01-06-2018 |
OncoResponse, Inc.
 OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Financieel Directeur/CFO | 01-06-2018 |
| CTI BIOPHARMA CORP. | Financieel Directeur/CFO | 01-01-2007 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Financieel Directeur/CFO | 01-01-2005 |
| ARS PHARMACEUTICALS, INC. | Financieel Directeur/CFO | - |
Opleiding van Russell Hawkinson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
39
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies for the treatment of infectious disease and inflammation | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology Discovers cancer immunotherapies by interrogating the human immune system | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
